Company / Current Liabilities
Pfizer Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$37.0B
FY2025
5-year range
$37.0B / $47.8B
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
#3 of 213
Health Care
What the data says
Among 213 Health Care companies, Pfizer is in the bottom 1% for current liabilities. Current Liabilities has fluctuated over the past 10 years, ranging from $25.9B in FY2020 to $47.8B in FY2023.
Based on SEC 10-K filings.
$37.0B in FY2025 with a 5-year CAGR of +7.4%. Ranks 3rd among 213 companies in Health Care.
Improved from $47.8B to $37.0B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- +7.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 213This company $37.0B Sector average $1.6B
▼
+2228.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.4%, indicating consistent growth.
- In FY2025, current liabilities decreased 14.0% year-over-year.
- Ranks #3 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $37.0B | -14.0% |
| FY2024 | $43.0B | -10.0% |
| FY2023 | $47.8B | +13.4% |
| FY2022 | $42.1B | -1.2% |
| FY2021 | $42.7B | +64.6% |
| FY2020 | $25.9B | -30.5% |
| FY2019 | $37.3B | +17.1% |
| FY2018 | $31.9B | +4.7% |
| FY2017 | $30.4B | -2.2% |
| FY2016 | $31.1B | +5.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026